Drug Trial Radar · NCT04756037
Study of the Safety and Contraceptive Efficacy of Relugolix Combination Therapy in Women With Uterine Fibroids or Endometriosis Who Are at Risk for Pregnancy
Last checked: Nov 20, 2026Latest source record: May 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,164
Actual
Start
Mar 18, 2021
Primary completion
Feb 25, 2025
Study completion Mar 31, 2026
Sponsor
- Lead sponsor
- Sumitomo Pharma Switzerland GmbHIndustry
- Sponsor type
- Industry
- First posted
- Feb 16, 2021
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 18 years, up to 50 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess the contraceptive efficacy of relugolix combination therapy.
Conditions
- Contraception
Interventions
Relugolix Combination TherapyDrug
Participants will receive orally 1 fixed-dose combination tablet (relugolix 40 mg/E2 1 mg/NETA 0.5 mg) once daily.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Contraceptive Efficacy of Relugolix Combination Therapy as Assessed by the At-Risk Pearl Index (PI)Time frame: 13 consecutive 28-day treatment cycles
Locations
112 sites in 2 countries. Site status is shown where the registry gives one.
Mobile
Mobile, Alabama
Chandler
Chandler, Arizona
Mesa
Mesa, Arizona
Peoria
Peoria, Arizona
Phoenix
Phoenix, Arizona
Burbank
Burbank, California
Canoga Park
Canoga Park, California
Encinitas
Encinitas, California
Gardena
Gardena, California
Lancaster
Lancaster, California
Long Beach
Long Beach, California
Long Beach
Long Beach, California
Palo Alto
Palo Alto, California
Sacramento
Sacramento, California
San Diego
San Diego, California
San Fernando
San Fernando, California
Valley Village
Valley Village, California
West Covina
West Covina, California
Aurora
Aurora, Colorado
Greenwood Village
Greenwood Village, Colorado
Washington
Washington D.C., District of Columbia
Washington
Washington D.C., District of Columbia
Aventura
Aventura, Florida
Boynton Beach
Boynton Beach, Florida
Davie
Davie, Florida
Deland
DeLand, Florida
Hialeah
Hialeah, Florida
Jacksonville
Jacksonville, Florida
Kissimmee
Kissimmee, Florida
Lake Worth
Lake Worth, Florida
Loxahatchee
Loxahatchee Groves, Florida
Margate
Margate, Florida
Miami
Miami, Florida
Miami
Miami, Florida
Miami
Miami, Florida
Miami
Miami, Florida
New Port Richey
New Port Richey, Florida
Orlando
Orlando, Florida
Orlando
Orlando, Florida
Panama City
Panama City, Florida
Showing 40 of 112 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.